Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Submitted by
admin
on March 11, 2017 - 11:55am
Source:
Fierce Pharma
News Tags:
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
Headline:
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Do Not Allow Advertisers to Use My Personal information
